SG Americas Securities’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $59K | Buy |
52,602
+18,100
| +52% | +$20.3K | ﹤0.01% | 2411 |
|
2025
Q1 | $27K | Sell |
34,502
-10,372
| -23% | -$8.12K | ﹤0.01% | 2936 |
|
2024
Q4 | $74K | Buy |
44,874
+10,511
| +31% | +$17.3K | ﹤0.01% | 2515 |
|
2024
Q3 | $120K | Sell |
34,363
-2,009
| -6% | -$7.02K | ﹤0.01% | 2596 |
|
2024
Q2 | $119K | Sell |
36,372
-1,084
| -3% | -$3.55K | ﹤0.01% | 2146 |
|
2024
Q1 | $275K | Sell |
37,456
-53,097
| -59% | -$390K | ﹤0.01% | 1553 |
|
2023
Q4 | $339K | Buy |
90,553
+16,911
| +23% | +$63.3K | ﹤0.01% | 1559 |
|
2023
Q3 | $156K | Buy |
+73,642
| New | +$156K | ﹤0.01% | 2244 |
|
2023
Q2 | – | Sell |
-11,000
| Closed | -$63K | – | 2217 |
|
2023
Q1 | $63K | Buy |
+11,000
| New | +$63K | ﹤0.01% | 2757 |
|
2022
Q3 | – | Sell |
-13,076
| Closed | -$324K | – | 2886 |
|
2022
Q2 | $324K | Sell |
13,076
-91,629
| -88% | -$2.27M | ﹤0.01% | 2125 |
|
2022
Q1 | $4.06M | Sell |
104,705
-315,485
| -75% | -$12.2M | 0.03% | 438 |
|
2021
Q4 | $24.6M | Buy |
420,190
+363,576
| +642% | +$21.3M | 0.13% | 90 |
|
2021
Q3 | $3.36M | Buy |
56,614
+3,543
| +7% | +$210K | 0.02% | 738 |
|
2021
Q2 | $4.61M | Buy |
53,071
+35,372
| +200% | +$3.07M | 0.02% | 579 |
|
2021
Q1 | $1.46M | Buy |
17,699
+14,820
| +515% | +$1.22M | 0.01% | 1141 |
|
2020
Q4 | $262K | Sell |
2,879
-74,392
| -96% | -$6.77M | ﹤0.01% | 2170 |
|
2020
Q3 | $3.09M | Buy |
77,271
+72,860
| +1,652% | +$2.91M | 0.02% | 405 |
|
2020
Q2 | $151K | Sell |
4,411
-21,024
| -83% | -$720K | ﹤0.01% | 2679 |
|
2020
Q1 | $565K | Buy |
+25,435
| New | +$565K | 0.01% | 1427 |
|
2019
Q2 | – | Sell |
-9,637
| Closed | -$169K | – | 2638 |
|
2019
Q1 | $169K | Buy |
+9,637
| New | +$169K | ﹤0.01% | 2351 |
|
2017
Q4 | – | Sell |
-10,596
| Closed | -$42K | – | 2672 |
|
2017
Q3 | $42K | Buy |
+10,596
| New | +$42K | ﹤0.01% | 2864 |
|